Why the study?
Endothelin-1 contributes to endothelial dysfunction and inflammation in CAD, and diabetes exacerbates vascular endothelial damage, motivating evaluation of ET-1 and its relation to CAD severity in diabetic patients.
Does plasma endothelin-1 (ET-1) level correlate with the severity of coronary artery disease in diabetic patients?
Does plasma endothelin-1 (ET-1) level correlate with the severity of coronary artery disease in diabetic patients?
Plasma endothelin-1 levels are significantly elevated in diabetic patients with coronary artery disease and correlate positively with angiographic disease severity.
Answers are grounded in this paper and cite their sources.
Plasma ET-1 may stratify risk in diabetic CAD patients; leaves open incremental prognostic utility beyond standard markers.
Background and Objectives: ET-1 has been demonstrated to play a role in endothelial dysfunction and inflammation, both of which are actively involved in the pathophysiology of the onset and progression of CAD. Diabetes mellitus (DM) increases the risk of CAD and has unfavorable effects on the vascular endothelium, hence, the importance of assessing this plasma marker and its relation to the severity of CAD in diabetic patients. The aim of this work is to study the prognostic value of the plasma level of the new marker, endothelin-1 (ET-1), in diabetic patients with coronary artery disease (CAD). Methods: Seventy patients with coronary artery lesions of not < 50% in at least one main coronary artery were randomized into 35 diabetics (Group I) and 35 nondiabetics (Group II). Twenty patients with normal coronaries as a control group (Group III) were also enrolled. The severity of coronary artery lesions was assessed by GINSINI score (GS) and SYNTAX score, and then, the relationship between them and ET-1 level was evaluated. Results: The ET-1 levels were significantly higher in Group I with higher GS values of 34.29 ± 11.7 points and SYNTAX scores of 18.4 ± 11.17 points than in Group II with lower GS values of 23.23 ± 8.14 points and SYNTAX of scores 12.06 ± 12.11 points (ET-1 was 187.93 ± 146.61 ng/L in Group I vs. 76.30 ± 91.83 ng/L in Group II, P = 0.001). ET-1 levels were significantly higher in Group I than in Group III (187.93 ± 146.61 ng/L vs. 26.16 ± 7.32 ng/L, P = 0.001). ET-1 levels were significantly higher in Group II than in Group III (76.30 ± 91.83 ng/L vs. 26.16 ± 7.32 ng/L, P = 0.001). Conclusion: There is a positive correlation between DM and both ET-1 levels and the severity of coronary artery lesions, P = 0.001.
No takes yet. Share an insight, caveat, or question.
Eldegwi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: